Frontiers in Oncology (May 2021)

The Role of Radiomics in Lung Cancer: From Screening to Treatment and Follow-Up

  • Radouane El Ayachy,
  • Radouane El Ayachy,
  • Radouane El Ayachy,
  • Nicolas Giraud,
  • Nicolas Giraud,
  • Paul Giraud,
  • Paul Giraud,
  • Paul Giraud,
  • Catherine Durdux,
  • Catherine Durdux,
  • Philippe Giraud,
  • Philippe Giraud,
  • Anita Burgun,
  • Anita Burgun,
  • Jean Emmanuel Bibault,
  • Jean Emmanuel Bibault,
  • Jean Emmanuel Bibault

DOI
https://doi.org/10.3389/fonc.2021.603595
Journal volume & issue
Vol. 11

Abstract

Read online

PurposeLung cancer represents the first cause of cancer-related death in the world. Radiomics studies arise rapidly in this late decade. The aim of this review is to identify important recent publications to be synthesized into a comprehensive review of the current status of radiomics in lung cancer at each step of the patients’ care.MethodsA literature review was conducted using PubMed/Medline for search of relevant peer-reviewed publications from January 2012 to June 2020ResultsWe identified several studies at each point of patient’s care: detection and classification of lung nodules (n=16), determination of histology and genomic (n=10) and finally treatment outcomes predictions (=23). We reported the methodology of those studies and their results and discuss the limitations and the progress to be made for clinical routine applications.ConclusionPromising perspectives arise from machine learning applications and radiomics based models in lung cancers, yet further data are necessary for their implementation in daily care. Multicentric collaboration and attention to quality and reproductivity of radiomics studies should be further consider.

Keywords